Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress.
The discovery of reliable and sensitive blood biomarkers is useful for the diagnosis, monitoring and potential future therapy of diseases. Recently, microRNAs (miRNAs) have been identified in blood circulation and might have the potential to be used as biomarkers for several diseases and clinical co...
Main Authors: | Andrie Koutsoulidou, Tassos C Kyriakides, George K Papadimas, Yiolanda Christou, Evangelia Kararizou, Eleni Zamba Papanicolaou, Leonidas A Phylactou |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4411125?pdf=render |
Similar Items
-
Circulating small RNA signatures differentiate accurately the subtypes of muscular dystrophies: small-RNA next-generation sequencing analytics and functional insights
by: Andrea C. Kakouri, et al.
Published: (2022-12-01) -
Six Serum miRNAs Fail to Validate as Myotonic Dystrophy Type 1 Biomarkers.
by: Juan M Fernandez-Costa, et al.
Published: (2016-01-01) -
TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2
by: Francesca Bosè, et al.
Published: (2019-09-01) -
Therapeutic potential of oleic acid supplementation in myotonic dystrophy muscle cell models
by: Nerea Moreno, et al.
Published: (2024-05-01) -
Quantitative magnetic resonance imaging assessment of muscle composition in myotonic dystrophy mice
by: Ariadna Bargiela, et al.
Published: (2023-01-01)